Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ipratropium manufacturers

7 products found

Filters

7 products found

ipratropium

Inhaler 20 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #15932

A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Manufacturer usually replies in 11 days

ipratropium

Nasal spray 125 mcg/ml, 250 mcg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Comments
Reference product : Atrovent (Boehringer Ingelheim)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

ipratropium

Inhalation solution 0.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18038
The primary mission of the company is to create new values to protect the lives and health of humankind and to improve the quality of life. They are striving to develop the world's leading new drugs through bold investments and cutting-edge research facilities.

Manufacturer usually replies in 5 days

ipratropium + xylometazoline hydrochloride

Nasal spray 230mcg/22mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
Taiwan
Manufacturer #9638
It is a company that is principally engaged in the manufacture and sales of various kinds of pharmaceuticals and medical equipment. The main products include respiratory drugs, cardiovascular and urinary drugs, gastrointestinal drugs, hormones, anti-tumor drugs, antibiotics, and health products. The company is also involved in the manufacture and sales of various kinds of cosmetics and animal medicines, as well as various kinds of chemical food additives and beverages. The company distributes its products in the domestic market and overseas markets.

Manufacturer usually replies in 6 days

salbutamol + ipratropium

Nebuliser solution 2.5 mg + 0.5 mg - 2.5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #6580
A pharmaceutical manufacturer based in the EU that has been active in 20+ countries selling its products in Europe, MENA, LATAM, Asia, and NA for 20+ years. Key production lines are Rx and medical devices. Main therapeutic areas include oncology and respiratory. The company's production lines are GMP-compliant.

Manufacturer usually replies in 11 days

salbutamol + ipratropium

Nebuliser solution 0.5 mg + 2.5 mg - 2.5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
Turkey
Unavailable markets
Kosovo , Qatar
Manufacturer #295
It is a 100% Europe-owned firm that makes and markets pharmaceuticals, a strategically vital commodity, and was founded in the 1950s. In the local pharmaceutical industry, it is ranked third out of 300 companies. It is one of the largest R&D centers in the European pharmaceutical business, with a 4,500+ square meter laboratory where it develops new medicines and contributes considerably to the European economy.

Manufacturer usually replies in 8 days

salbutamol + ipratropium

Nebuliser solution 2,5mg+500mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #7486

Manufacturer usually replies in nan days

IPRATROPIUM Manufacturers

Markets of interest

As a bronchodilator IPRATROPIUM is used to prevent bronchospasm in people with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema. The drug is commonly administered through inhalation which allows producing a local effect without presenting a significant systemic absorption. The substance is available for sale in the form of an inhaler, nasal spray, inhalation solution, pressurized inhalation, nebulizer solution, inhalation vapor, from manufacturers in various countries including Y. The drug is provided by a wide range of IPRATROPIUM suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading IPRATROPIUM manufacturers and distributors are based in China.

Licensing and brand names

IPRATROPIUM as a therapeutic agent was first approved by the FDA in November 1986. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Atrovent, Atrovent HFA, DuoNeb, Combivent, Combivent Respimat. One of the most popular branded versions of IPRATROPIUM is manufactured and supplied by the Chinese pharmaceutical company Jewim Pharmaceutical (Shandong) Co., LTD. Other manufacturing companies and distributors from European Union, Canada, India, Russia, Taiwan have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with IPRATROPIUM as an active ingredient.

Target supply price

The wholesale acquisition cost of ipratropium inhalation solution (500 mcg/2.5 mL) is around $15 for a supply of 75 milliliters. The retail price of 200 doses of the substance compressed inhalation solution in Europe reaches 7.16 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the IPRATROPIUM manufacturers and suppliers that you are looking for. You can also find the dossier status of IPRATROPIUM and the GMP approvals of the different variants of the medication. The product description of all IPRATROPIUM suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where IPRATROPIUM is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.